Literature DB >> 33911158

Activation of (pro)renin by (pro)renin receptor in extracellular vesicles from osteoclasts.

Jonathan B Murray1, Christy Mikhael1, Guanghong Han2, Lorraine Perciliano de Faria3, Wellington J Rody4, L Shannon Holliday5,6,7.   

Abstract

The (pro)renin receptor (PRR) is a multifunctional integral membrane protein that serves as a component of the vacuolar H+-ATPase (V-ATPase) and also activates (pro)renin. We recently showed that full-length PRR, found as part of a V-ATPase sub-complex, is abundant in extracellular vesicles shed by osteoclasts. Here, we tested whether these extracellular vesicles stimulate (pro)renin. Extracellular vesicles isolated from the conditioned media of RAW 264.7 osteoclast-like cells or primary osteoclasts were characterized and counted by nanoparticle tracking. Immunoblotting confirmed that full-length PRR was present. Extracellular vesicles from osteoclasts dose-dependently stimulated (pro)renin activity, while extracellular vesicles from 4T1 cancer cells, in which we did not detect PRR, did not activate (pro)renin. To confirm that the ability of extracellular vesicles from osteoclasts to stimulate (pro)renin activity was due to the PRR, the "handle region peptide" from the PRR, a competitive inhibitor of PRR activity, was tested. It dose-dependently blocked the ability of extracellular vesicles to stimulate the enzymatic activity of (pro)renin. In summary, the PRR, an abundant component of extracellular vesicles shed by osteoclasts, stimulates (pro)renin activity. This represents a novel mechanism by which extracellular vesicles can function in intercellular regulation, with direct implications for bone biology.

Entities:  

Year:  2021        PMID: 33911158     DOI: 10.1038/s41598-021-88665-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  27 in total

Review 1.  The skeletal renin-angiotensin system: A potential therapeutic target for the treatment of osteoarticular diseases.

Authors:  Jingjing Zhao; Hao Yang; Bo Chen; Rui Zhang
Journal:  Int Immunopharmacol       Date:  2019-04-16       Impact factor: 4.932

Review 2.  Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?

Authors:  Mark C Chappell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-16       Impact factor: 4.733

Review 3.  Local Renin Angiotensin Aldosterone Systems and Cardiovascular Diseases.

Authors:  Walmor C De Mello
Journal:  Med Clin North Am       Date:  2017-01       Impact factor: 5.456

4.  Postmenopausal osteoporosis is associated with elevated aldosterone/renin ratio.

Authors:  Xiaoyu Shu; Mei Mei; Linqiang Ma; Zhihong Wang; Shumin Yang; Jinbo Hu; Ying Song; Wenwen He; Ting Luo; Qingfeng Cheng; Yue Wang; Qianna Zhen; Qifu Li
Journal:  J Hum Hypertens       Date:  2018-05-22       Impact factor: 3.012

5.  Involvement of Renin-Angiotensin System in Damage of Angiotensin-Converting Enzyme Inhibitor Captopril on Bone of Normal Mice.

Authors:  Jin-Xin Liu; Liang Wang; Yan Zhang
Journal:  Biol Pharm Bull       Date:  2015       Impact factor: 2.233

6.  Renin inhibition improves ovariectomy-induced osteoporosis of lumbar vertebra in mice.

Authors:  Fang-Yi Zhang; Feng-Jian Yang; Jiu-Lin Yang; Liang Wang; Yan Zhang
Journal:  Biol Pharm Bull       Date:  2014       Impact factor: 2.233

7.  Local renin-angiotensin system is associated with bone mineral density of glucocorticoid-induced osteoporosis patients.

Authors:  B Shuai; Y P Yang; L Shen; R Zhu; X J Xu; C Ma; L Lv; J Zhao; J H Rong
Journal:  Osteoporos Int       Date:  2014-12-17       Impact factor: 4.507

8.  Reciprocal roles of angiotensin II and Angiotensin II Receptors Blockade (ARB) in regulating Cbfa1/RANKL via cAMP signaling pathway: possible mechanism for hypertension-related osteoporosis and antagonistic effect of ARB on hypertension-related osteoporosis.

Authors:  Xiao-Xu Guan; Yi Zhou; Ji-Yao Li
Journal:  Int J Mol Sci       Date:  2011-06-27       Impact factor: 5.923

9.  Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients.

Authors:  Suguru Yamamoto; Ryo Kido; Yoshihiro Onishi; Shingo Fukuma; Tadao Akizawa; Masafumi Fukagawa; Junichiro J Kazama; Ichiei Narita; Shunichi Fukuhara
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

10.  The proteome of extracellular vesicles released by clastic cells differs based on their substrate.

Authors:  Wellington J Rody; Casey A Chamberlain; Alyssa K Emory-Carter; Kevin P McHugh; Shannon M Wallet; Victor Spicer; Oleg Krokhin; L Shannon Holliday
Journal:  PLoS One       Date:  2019-07-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.